Clinical Trial Update: Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance [Phase 2]

View source ↗

Summary

This clinical trial update summarizes a Phase 2 study evaluating precision immuno-oncology approaches in advanced non-small cell lung cancer patients with resis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING